John A. Tattory

VP, Principal Acct Officer, WINDTREE THERAPEUTICS INC /DE/.

Companies

Transcode Therapeutics, Inc.Chief financial officer Sep 21, 2026 to now¹
WINDTREE THERAPEUTICS INC /DE/Chief financial officer Feb 17, 2015 to Feb 3, 2023²
WINDTREE THERAPEUTICS INC /DE/VP, Principal Acct Officer Aug 26, 2010 to Mar 10, 2014³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTranscode Therapeutics, Inc., Chief financial officer
2
SEC EDGARWINDTREE THERAPEUTICS INC /DE/, Chief financial officer
3
SEC EDGARWINDTREE THERAPEUTICS INC /DE/, VP, Principal Acct Officer